{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T22:08:04Z","timestamp":1783721284367,"version":"3.55.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100008484","name":"BioMarin Pharmaceutical Inc.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008484","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012233","name":"Abeona Therapeutics Inc.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012233","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Regenexbio Inc."},{"name":"CereSpir Inc."},{"DOI":"10.13039\/100008484","name":"BioMarin Pharmaceutical Inc.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008484","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.bbadis.2020.165681","type":"journal-article","created":{"date-parts":[[2020,1,8]],"date-time":"2020-01-08T16:38:47Z","timestamp":1578501527000},"page":"165681","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Future perspectives: What lies ahead for Neuronal Ceroid Lipofuscinosis research?"],"prefix":"10.1016","volume":"1866","author":[{"given":"Jonathan D.","family":"Cooper","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara E.","family":"Mole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2020.165681_bb0005","article-title":"Applying modern omic technologies to the neuronal ceroid lipofuscinoses","author":"Kline","year":"2019","journal-title":"Biochim Biophys Acta Mol Basis Dis."},{"key":"10.1016\/j.bbadis.2020.165681_bb0010","article-title":"Overview of advances in educational and social supports for young persons with NCL disorders","volume":"165480","author":"Elmerskog","year":"2019","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.bbadis.2020.165681_bb0015","article-title":"Cellular models of Batten disease","volume":"165559","author":"Minnis","year":"2019","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.bbadis.2020.165681_bb0020","article-title":"The contribution of multicellular model organisms to neuronal ceroid lipofuscinosis research","volume":"165614","author":"Huber","year":"2019","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.bbadis.2020.165681_bb0025","article-title":"Pharmacological approaches to tackle NCLs","volume":"165553","author":"Kauss","year":"2019","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.bbadis.2020.165681_bb0030","article-title":"Pathomechanisms in the neuronal ceroid lipofuscinoses","volume":"165570","author":"Nelvagal","year":"2019","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.bbadis.2020.165681_bb0035","article-title":"Moving towards a new era of genomics in the neuronal ceroid lipofuscinoses","volume":"165571","author":"Butz","year":"2019","journal-title":"Biochim Biophys Acta Mol Basis Dis."},{"key":"10.1016\/j.bbadis.2020.165681_bb0040","article-title":"Cardiac pathology in neuronal ceroid lipofuscinoses (NCL): More than a mere co-morbidity","volume":"165643","author":"Schulz","year":"2019","journal-title":"Biochim Biophys Acta Mol Basis Dis."},{"key":"10.1016\/j.bbadis.2020.165681_bb0045","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S1474-4422(18)30368-5","article-title":"Clinical challenges and future therapeutic approaches for neuronal ceroid lipofuscinosis","volume":"18","author":"Mole","year":"2019","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bbadis.2020.165681_bb0050","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1016\/j.bbadis.2015.05.011","article-title":"Genetics of the neuronal ceroid lipofuscinoses (Batten disease)","volume":"1852","author":"Mole","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2020.165681_bb0055","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1016\/j.bbadis.2015.05.014","article-title":"Towards a new understanding of NCL pathogenesis","volume":"1852","author":"Cooper","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2020.165681_bb0060","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13024-018-0300-6","article-title":"Emerging new roles of the lysosome and neuronal ceroid lipofuscinoses","volume":"14","author":"Mukherjee","year":"2019","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.bbadis.2020.165681_bb0065","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/s41556-018-0228-7","article-title":"CLN8 is an endoplasmic reticulum cargo receptor that regulates lysosome biogenesis","volume":"20","author":"di Ronza","year":"2018","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbadis.2020.165681_bb0070","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/s41582-019-0138-8","article-title":"Therapeutic landscape for Batten disease: current treatments and future prospects","volume":"15","author":"Johnson","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.bbadis.2020.165681_bb0075","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1016\/j.bbadis.2015.04.027","article-title":"Cell biology of the NCL proteins: What they do and don\u2019t do","volume":"1852","author":"C\u00e1rcel-Trullols","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.bbadis.2020.165681_bb0080","doi-asserted-by":"crossref","first-page":"23847","DOI":"10.1074\/jbc.M002758200","article-title":"Structural basis for the insensitivity of a serine enzyme (palmitoyl-protein thioesterase) to phenylmethylsulfonyl fluoride","volume":"275","author":"Das","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2020.165681_bb0085","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s40478-017-0476-y","article-title":"Glial cells are functionally impaired in juvenile neuronal ceroid lipofuscinosis and detrimental to neurons","volume":"5","author":"Parviainen","year":"2017","journal-title":"Acta Neuropathol Commun."},{"key":"10.1016\/j.bbadis.2020.165681_bb0090","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s40478-018-0575-4","article-title":"Compromised astrocyte function and survival negatively impact neurons in infantile neuronal ceroid lipofuscinosis","volume":"6","author":"Lange","year":"2018","journal-title":"Acta Neuropathol Commun."},{"key":"10.1016\/j.bbadis.2020.165681_bb0095","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1038\/mt.2009.170","article-title":"During, efficient gene delivery and selective transduction of glial cells in the mammalian brain by AAV serotypes isolated from nonhuman primates","volume":"17","author":"Lawlor","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.bbadis.2020.165681_bb0100","doi-asserted-by":"crossref","first-page":"E5920","DOI":"10.1073\/pnas.1701832114","article-title":"Synergistic effects of treating the spinal cord and brain in CLN1 disease","volume":"114","author":"Shyng","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2020.165681_bb0105","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2350\/07-03-0242.1","article-title":"A murine model of infantile neuronal ceroid lipofuscinosis-ultrastructural evaluation of storage in the central nervous system and viscera","volume":"11","author":"Galvin","year":"2008","journal-title":"Pediatr. Dev. Pathol."},{"key":"10.1016\/j.bbadis.2020.165681_bb0110","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.autneu.2018.07.003","article-title":"Paroxysmal sympathetic hyperactivity in juvenile neuronal ceroid lipofuscinosis (Batten disease)","volume":"214","author":"Ostergaard","year":"2018","journal-title":"Auton. Neurosci."},{"key":"10.1016\/j.bbadis.2020.165681_bb0115","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1212\/WNL.0b013e31821435bd","article-title":"Cardiac involvement in juvenile neuronal ceroid lipofuscinosis (Batten disease)","volume":"76","author":"Ostergaard","year":"2011","journal-title":"Neurology."},{"key":"10.1016\/j.bbadis.2020.165681_bb0120","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.brainresbull.2012.03.003","article-title":"Mouse models of neuronal ceroid lipofuscinoses: useful pre-clinical tools to delineate disease pathophysiology and validate therapeutics","volume":"88","author":"Shacka","year":"2012","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.bbadis.2020.165681_bb0125","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1016\/j.bbadis.2013.01.009","article-title":"Use of model organisms for the study of neuronal ceroid lipofuscinosis","volume":"1832","author":"Bond","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2020.165681_bb0130","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1016\/j.ymthe.2018.07.015","article-title":"Longitudinal in vivo monitoring of the CNS demonstrates the efficacy of gene therapy in a sheep model of CLN5 batten disease","volume":"26","author":"Mitchell","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.bbadis.2020.165681_bb0135","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1016\/j.ymgme.2018.12.198","article-title":"Characterization of a novel porcine model of CLN3-Batten disease","volume":"126","author":"Johnson","year":"2019","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bbadis.2020.165681_bb0140","doi-asserted-by":"crossref","first-page":"9891","DOI":"10.1038\/s41598-019-45859-9","article-title":"CRISPR\/Cas9 mediated generation of an ovine model for infantile neuronal ceroid lipofuscinosis (CLN1 disease)","volume":"9","author":"Eaton","year":"2019","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.bbadis.2020.165681_bb0145","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1007\/s40265-017-0771-8","article-title":"Cerliponase alfa: first global approval","volume":"77","author":"Markham","year":"2017","journal-title":"Drugs."},{"key":"10.1016\/j.bbadis.2020.165681_bb0150","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1056\/NEJMoa1712649","article-title":"Study of intraventricular cerliponase alfa for CLN2 disease","volume":"378","author":"Schulz","year":"2018","journal-title":"N Engl J Med."},{"key":"10.1016\/j.bbadis.2020.165681_bb0165","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.ymthe.2018.02.027","article-title":"Prevention of photoreceptor cell loss in a Cln6nclf mouse model of batten disease requires CLN6 gene transfer to bipolar cells","volume":"26","author":"Kleine Holthaus","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.bbadis.2020.165681_bb0170","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1089\/hum.2017.048","article-title":"AAV: an overview of unanswered questions","volume":"28","author":"Berns","year":"2017","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.bbadis.2020.165681_bb0175","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s40263-019-00620-8","article-title":"Current and emerging treatment strategies for neuronal ceroid lipofuscinoses","volume":"33","author":"Kohlsch\u00fctter","year":"2019","journal-title":"CNS Drugs."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092544392030020X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092544392030020X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T04:56:22Z","timestamp":1760417782000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092544392030020X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":33,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S092544392030020X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2020.165681","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Future perspectives: What lies ahead for Neuronal Ceroid Lipofuscinosis research?","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2020.165681","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"165681"}}